Yu‐Ling Lin
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA Interference and Gene Delivery
Papers in ⓘ
-
- RNA Interference and Gene Delivery 9
- RNA modifications and cancer 4
- Advanced biosensing and bioanalysis techniques 4
- Angiogenesis and VEGF in Cancer 4
- Immunology 14
- Immunotherapy and Immune Responses 4
- Co-authors
- Kuang‐Wen Liao (24 shared papers)Feng‐Mao Lin (1 shared paper)Shun‐Long Weng (2 shared papers)Chun-Chi Liu (1 shared paper)Shu-Yi Ho (1 shared paper)Yu‐Ting Tseng (1 shared paper)Hsien‐Da Huang (1 shared paper)Chih‐Hung Chou (1 shared paper)
- Journals
- Scientific Reports (4 papers)Molecules (3 papers)International Journal of Molecular Sciences (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Journal of Nanobiotechnology (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Yu‐Ling Lin
111 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 763
- Molecular Biology 1.2k
- Molecular Medicine 81
- Water Science and Technology 181
- Biomaterials 158
Countries citing papers authored by Yu‐Ling Lin
This map shows the geographic impact of Yu‐Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ling Lin more than expected).
Fields of papers citing papers by Yu‐Ling Lin
This network shows the impact of papers produced by Yu‐Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ling Lin. The network helps show where Yu‐Ling Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions Hit paper breakdown → | 2013 | 892 |
| 2 | 2007 | 180 | |
| 3 | 2011 | 113 | |
| 4 | 2013 | 97 | |
| 5 | 2004 | 62 | |
| 6 | 2018 | 61 | |
| 7 | 2020 | 55 | |
| 8 | 2016 | 52 | |
| 9 | 2014 | 46 | |
| 10 | 2016 | 45 | |
| 11 | 2016 | 41 | |
| 12 | 2019 | 38 | |
| 13 | 2019 | 34 | |
| 14 | 2021 | 27 | |
| 15 | 2019 | 27 | |
| 16 | 2021 | 27 | |
| 17 | 2012 | 25 | |
| 18 | 2012 | 24 | |
| 19 | 2020 | 24 | |
| 20 | 2015 | 23 |
About Yu‐Ling Lin
Yu‐Ling Lin is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Cancer Research and Electrical and Electronic Engineering, having authored 119 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (5 papers), Neurological Disease Mechanisms and Treatments (5 papers), RNA modifications and cancer (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Virus-based gene therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Cancer Research (763 citations), Molecular Biology (1.2k citations), Molecular Medicine (81 citations), Water Science and Technology (181 citations) and Biomaterials (158 citations). Yu‐Ling Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Kuang‐Wen Liao, Feng‐Mao Lin, Shun‐Long Weng, Chun-Chi Liu, Shu-Yi Ho, Yu‐Ting Tseng, Hsien‐Da Huang, Chih‐Hung Chou, Sirjana Shrestha and I‐En Liao. Their work appears in journals such as Scientific Reports, Molecules, International Journal of Molecular Sciences, Journal of Experimental & Clinical Cancer Research and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.